Stay updated on Long-term Esketamine Study in Depression: Clinical Trial
Sign up to get notified when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.

Latest updates to the Long-term Esketamine Study in Depression: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.3%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.5%
- Check62 days agoChange DetectedThe webpage has updated its version from v2.15.0 to v2.15.2 and has removed older dates from March 2025, replacing them with newer dates in April 2025.SummaryDifference0.2%
- Check76 days agoChange DetectedThe page has been updated to include new information about treatment-resistant depression, specifically mentioning the oral antidepressants Sertraline and Venlafaxine XR, as well as a new identifier for a study. The previous detailed description of the study's methodology and phases has been removed.SummaryDifference11%
- Check84 days agoChange DetectedThe page has been updated to reflect the latest version as v2.14.4, replacing the previous version v2.14.3. The estimated last update posted has been removed.SummaryDifference0.0%
Stay in the know with updates to Long-term Esketamine Study in Depression: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.